BACKGROUND: Rho GTPases are known to play important roles in regulating multiple cellular processes that include cell polarization and migration. Among these Rho GTPases, Rac has been shown to be essential for F actin formation and cell migration. P-Rex1 is a guanine nucleotide exchange factor (GEF) that was previously found to mediate the activation of Rac2, but not Rac1, in mouse neutrophils. OBJECTIVES: Here we examined the role of P-Rex1 in mouse macrophages and atherogenesis. METHODS AND RESULTS: PBD (p21 binding domain) pull down assay was performed to compare the Rac1 activation in WT and P-Rex1-deficient macrophage. In addition, transwell assay was conducted to compare chemotaxis of WT and P-Rex1-deficient macrophage. We found that P-Rex1 is a major Rac1 regulator in mouse macrophages as its deficiency significantly compromises macrophage chemotaxis, superoxide production (SOD), and Rac1 activation in response to chemoattractants. The potential role of P-Rex1 in atherogenesis is also investigated by transferring P-Rex1-deficient bone marrow cells to LDLR deficient mice. Contrary to our prediction, P-Rex1 deficiency did not alter atherogenesis, suggesting chemoattractant-induced macrophage migration may not have a significant role in atherogenesis. CONCLUSIONS: P-Rex1 is one of the major GEFs in macrophage regulating Rac1 activation and chemotaxis.
BACKGROUND: Rho GTPases are known to play important roles in regulating multiple cellular processes that include cell polarization and migration. Among these Rho GTPases, Rac has been shown to be essential for F actin formation and cell migration. P-Rex1 is a guanine nucleotide exchange factor (GEF) that was previously found to mediate the activation of Rac2, but not Rac1, in mouse neutrophils. OBJECTIVES: Here we examined the role of P-Rex1 in mouse macrophages and atherogenesis. METHODS AND RESULTS: PBD (p21 binding domain) pull down assay was performed to compare the Rac1 activation in WT and P-Rex1-deficient macrophage. In addition, transwell assay was conducted to compare chemotaxis of WT and P-Rex1-deficient macrophage. We found that P-Rex1 is a major Rac1 regulator in mouse macrophages as its deficiency significantly compromises macrophage chemotaxis, superoxide production (SOD), and Rac1 activation in response to chemoattractants. The potential role of P-Rex1 in atherogenesis is also investigated by transferring P-Rex1-deficient bone marrow cells to LDLR deficient mice. Contrary to our prediction, P-Rex1 deficiency did not alter atherogenesis, suggesting chemoattractant-induced macrophage migration may not have a significant role in atherogenesis. CONCLUSIONS:P-Rex1 is one of the major GEFs in macrophage regulating Rac1 activation and chemotaxis.
Authors: Heidi C E Welch; W John Coadwell; Christian D Ellson; G John Ferguson; Simon R Andrews; Hediye Erdjument-Bromage; Paul Tempst; Phillip T Hawkins; Len R Stephens Journal: Cell Date: 2002-03-22 Impact factor: 41.582
Authors: G M Doody; S E Bell; E Vigorito; E Clayton; S McAdam; R Tooze; C Fernandez; I J Lee; M Turner Journal: Nat Immunol Date: 2001-06 Impact factor: 25.606
Authors: Angeliki Malliri; Rob A van der Kammen; Kristopher Clark; Maarten van der Valk; Frits Michiels; John G Collard Journal: Nature Date: 2002-06-20 Impact factor: 49.962
Authors: Keiko Fujikawa; Ana V Miletic; Frederick W Alt; Roberta Faccio; Tracie Brown; Jeremy Hoog; Jessica Fredericks; Shinzo Nishi; Shirly Mildiner; Sheri L Moores; Joan Brugge; Fred S Rosen; Wojciech Swat Journal: J Exp Med Date: 2003-11-17 Impact factor: 14.307
Authors: Heidi C E Welch; Alison M Condliffe; Laura J Milne; G John Ferguson; Kirsti Hill; Louise M C Webb; Klaus Okkenhaug; W John Coadwell; Simon R Andrews; Marcus Thelen; Gareth E Jones; Phillip T Hawkins; Len R Stephens Journal: Curr Biol Date: 2005-10-25 Impact factor: 10.834
Authors: Chiara Pantarelli; Dingxin Pan; Stephen Chetwynd; Anne-Katrien Stark; Kirsti Hornigold; Polly Machin; Laraine Crossland; Simon J Cleary; Martin J Baker; Elizabeth Hampson; Anna Mandel; Anne Segonds-Pichon; Rachael Walker; Cornelis van 't Veer; Yanira Riffo-Vasquez; Klaus Okkenhaug; Simon Pitchford; Heidi C E Welch Journal: Blood Adv Date: 2021-08-24
Authors: J Qin; Y Xie; B Wang; M Hoshino; D W Wolff; J Zhao; M A Scofield; F J Dowd; M-F Lin; Y Tu Journal: Oncogene Date: 2009-03-23 Impact factor: 9.867